Skip to content

VanishPointRecalls & reported problems across all models

Retractable Technologies, Inc. · 9 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
45
Deaths reported
0
Injuries reported
1
Recalls
0

We found 9 models of VanishPoint by Retractable Technologies, Inc. in the FDA's device registry (GUDID). Together they are named in 45 adverse event reports in the FDA's MAUDE database, received between Nov 7, 2017 and Jun 5, 2026 — classified as 1 injury, 44 malfunctions.

The most frequently reported specific device problem is “Retraction Problem” (17 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 2 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported VanishPoint problems

Device problems

  • Retraction Problem17
  • Fluid/Blood Leak6
  • Break2
  • Defective Device2
  • Leak/Splash2
  • Therapeutic or Diagnostic Output Failure2
  • Activation, Positioning or Separation Problem1
  • Backflow1

Patient problems

  • No Clinical Signs, Symptoms or Conditions16
  • No Known Impact Or Consequence To Patient11
  • Insufficient Information4
  • Chemical Exposure3
  • Underdose3
  • Missed Dose2
  • No Information2
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1

VanishPoint models

9 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent VanishPoint adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Retractable Technologies, Inc. products

All Retractable Technologies, Inc. devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page